Pills and Pens Bring Hope for Drug Companies in Diabetes CrunchBy
Companies develop oral treatments, work with Google parent
Diabetes market has unprecedented competition, Novo says
Drugmakers facing a price war in the diabetes market are betting on new technologies to withstand the competition.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.